Merck Manual

Please confirm that you are a health care professional

honeypot link

IgG4-Related Sclerosing Cholangitis

By

Yedidya Saiman

, MD, PhD, Lewis Katz School of Medicine, Temple University

Reviewed/Revised Aug 2023
View PATIENT EDUCATION

IgG4-related sclerosing cholangitis (IgG4-SC) is a rare cholangiopathy that causes symptoms similar to those of primary sclerosing cholangitis. IgG4-SC can manifest with cholangitis and pancreatitis. Diagnosis requires an abnormal cholangiogram, elevated serum IgG4 levels, and histologic analysis. Treatment with corticosteroids leads to dramatic and lasting remission.

IgG4-related sclerosing cholangitis (IgG4-SC) is a biliary stricturing disease caused by an IgG4-predominant subepithelial lymphoplasmacytic infiltration of intrahepatic and extrahepatic bile ducts.

General reference

  • 1. Umehara H, Okazaki K, Masaki Y, et al: A novel clinical entity, IgG4-related disease (IgG4RD): General concept and details. Mod Rheumatol 22(1):1-14, 2012. doi: 10.1007/s10165-011-0508-6

Symptoms and Signs of IgG4-SC

Diagnosis of IgG4-SC

  • Cholangiogram

  • IgG4 levels

  • Histology tests

IgG4-SC should be considered particularly in patients with pancreatitis plus cholangiopathy. Accurate differentiation of IgG4-SC from other forms of sclerosing cholangitis is critical because IgG4-SC requires different treatment and confers favorable outcomes. Diagnosis requires an atypical cholangiogram, elevated IgG4 levels (in most, but not all, patients) and representative histological features, including a diffuse lymphoplasmacytic infiltrate enriched in IgG4-positive plasma cells of both intra- and extra-hepatic bile duct walls, storiform (“cartwheel”) fibrosis, and preserved bile duct epithelial layer. Particularly in older patients, IgG4-SC can be misdiagnosed as hepatobiliary malignancy.

Treatment of IgG4-SC

  • Corticosteroids

Corticosteroids (monotherapy with prednisone) are the mainstay of treatment of IgG4-related sclerosing cholangitis. The goal is to induce complete remission. Treatment with high doses leads to rapid biochemical and symptomatic improvement with decreasing serum IgG4 levels, often preventing the need for biliary stenting. Complete remission can be achieved with corticosteroid (prednisone) monotherapy; maintenance therapy is required in most patients; the rate of relapse approaches 50% (1 Treatment reference IgG4-related sclerosing cholangitis (IgG4-SC) is a rare cholangiopathy that causes symptoms similar to those of primary sclerosing cholangitis. IgG4-SC can manifest with cholangitis and pancreatitis... read more ). In patients who fail corticosteroid therapy, rituximab is also an effective treatment.

Treatment reference

  • 1. Sandanayake NS, Church NI, Chapman MH, et al: Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol 7(10):1089-1096. doi: 10.1016/j.cgh.2009.03.021

Key Points

  • IgG-SC is a unique cholangiopathy, distinct from PSC.

  • Suspect IgG-SC particularly in patients with both pancreatitis and cholangiopathy.

  • Diagnosis requires an abnormal cholangiogram, elevated serum IgG4 levels, and histologic analysis.

  • Treatment with corticosteroids leads to dramatic and lasting remission.

Drugs Mentioned In This Article

Drug Name Select Trade
Deltasone, Predone, RAYOS, Sterapred, Sterapred DS
RIABNI, Rituxan, RUXIENCE, truxima
View PATIENT EDUCATION
NOTE: This is the Professional Version. CONSUMERS: View Consumer Version
quiz link

Test your knowledge

Take a Quiz! 
iOS ANDROID
iOS ANDROID
iOS ANDROID
TOP